Forus Health Private Limited, a Bengaluru-based medical devices company focused on developing state-of-the-art ophthalmic devices, has announced the launch of 3nethra NEO, which is a Retinopathy of Prematurity (ROP) imaging platform.
Forus Health – Overview
Founded in 2010, Forus Health aims to eradicate preventable blindness using technology. It has successfully deployed thousands of its flagship adult retinal imaging device – 3nethra classic in 25 countries.
Understanding Retinopathy of Prematurity (ROP)
- The leading cause of blindness in infants in the world.
- In India, one out of three babies born less than 2,000 grams develops the disease and 10 percent of the babies will turn blind at the age of 2 months if not treated on time.
- Annually, over 3.5 million babies are born premature in India.
- Less than 100 ROP specialists nationwide to screen & treat this condition.
3nethra NEO – Key Takeaways
- Result of consistent efforts to build affordable & state-of-the-art imaging solutions for eye care.
- One of solutions of collaboration with Narayana Nethralaya for clinical trials.
- Most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis.
- The device costs one fourth of its nearest competitor.
- Quality was found to be at par with the imported cameras during clinical trials.
- Found to be useful for telemedicine settings during clinical trials under Narayana Nethralaya’s KIDROP outreach programme
3nethra NEO – Key Features
- Has four design patents for this product to protect design.
- A light weight & compact wide-angle imaging device.
- Its skillfully designed optics, ergonomic natural grip for easy holding & high reliability enhanced by a unique focusing and illumination system makes it an ideal choice for neonatal ICUs.
Understanding the Karnataka Internet Assisted Diagnosis of Retinopathy of Prematurity (KIDROP) Programme
- In 2007, Narayana Nethralaya pioneered an ROP screening programme called KIDROP.
- Screens premature infants in rural areas & detects and treats this condition using a unique telemedicine model.
- It is currently the world’s largest tele-ROP programme that serves over 102 rural units.
- Cited by the United Nations Development Programme (UNDP), Niti Ayog or the National Institution for Transforming India, Harvard Business Review, IIM-A, IIM-B and been validated by the CDC Atlanta guidelines.
- In June 2016, KIDROP was awarded the National Award for HealthCare Excellence for Rural Outreach.